NYSE:LLY

Eli Lilly and Short Interest Ratio and Short Volume

$230.46
-3.27 (-1.40 %)
(As of 09/16/2021 01:51 PM ET)
Add
Compare
Today's Range
$229.76
$233.34
50-Day Range
$231.47
$272.71
52-Week Range
$129.21
$275.87
Volume52,092 shs
Average Volume3.54 million shs
Market Capitalization$221.02 billion
P/E Ratio34.55
Dividend Yield1.46%
Beta0.25

Eli Lilly and (NYSE:LLY) Short Interest Data

Current Short Volume6,150,000 shares
Previous Short Volume6,150,000 shares
Change Vs. Previous MonthNo Change
Dollar Volume Sold Short$1.59 billion
Short Interest Ratio / Days to Cover2.2
Last Record DateAugust, 31 2021
Outstanding Shares959,025,000 shares
Float Size795,050,000 shares
Short Percent of Float0.77%
Today's Trading Volume52,092 shares
Average Trading Volume3,535,972 shares
Today's Volume Vs. Average-98.53%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Eli Lilly and ?

Sign up to receive the latest short interest report for Eli Lilly and and its competitors with MarketBeat's FREE newsletter.

Eli Lilly and (NYSE:LLY) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/20216,150,000 shares $1.59 billion No Change0.8%2.2 $258.29
8/13/20216,150,000 shares $1.62 billion -9.2%0.8%1.9 $264.21
7/30/20216,770,000 shares $1.65 billion -3.4%0.9%2.1 $243.50
7/15/20217,010,000 shares $1.62 billion +12.0%0.9%2.1 $231.47
6/30/20216,260,000 shares $1.44 billion -17.6%0.8%1.8 $229.52
6/15/20217,600,000 shares $1.70 billion +0.1%1.0%2.2 $223.52
5/28/20217,590,000 shares $1.52 billion -8.4%1.0%2.1 $199.74
5/14/20218,290,000 shares $1.62 billion -7.0%1.0%2.5 $194.94
4/30/20218,910,000 shares $1.62 billion +39.7%1.1%2.6 $182.20
4/15/20216,380,000 shares $1.17 billion -17.4%0.8%1.7 $183.00
3/31/20217,720,000 shares $1.43 billion +10.6%1.0%1.8 $185.50
3/15/20216,980,000 shares $1.45 billion +23.8%0.9%1.6 $208.08
2/26/20215,640,000 shares $1.15 billion -14.0%0.7%1.3 $203.82
2/12/20216,560,000 shares $1.33 billion -1.7%0.8%1.5 $202.58
1/29/20216,670,000 shares $1.40 billion +15.8%0.8%1.5 $210.12
1/15/20215,760,000 shares $1.08 billion +10.8%0.7%1.2 $186.69
12/31/20205,200,000 shares $868.45 million -24.5%0.7%1.2 $167.01
12/15/20206,890,000 shares $1.09 billion +24.1%0.9%1.7 $157.91
11/30/20205,550,000 shares $818.29 million +4.1%0.7%1.3 $147.44
11/15/20205,330,000 shares $758.89 million +9.0%0.7%1.3 $142.38
10/30/20204,890,000 shares $648.17 million -7.4%0.6%1.3 $132.55
10/15/20205,280,000 shares $783.87 million +40.1%0.7%1.6 $148.46
9/30/20203,770,000 shares $558.04 million -39.9%0.5%1.2 $148.02
9/15/20206,270,000 shares $941.00 million +34.6%0.8%2 $150.08
8/31/20204,660,000 shares $691.50 million +9.7%0.6%1.5 $148.39

Institutional Investors Shorting Eli Lilly and (NYSE:LLY)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of Eli Lilly and. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
9/13/2021Bank of America Corp DE81,500203,300+149.4%$46,661.00
8/31/2021Pathstone Family Office LLCN/A4,564N/A$1,048.00
8/20/2021Jefferies Group LLC26,5001,000-96.2%$230.00
8/17/2021Wells Fargo & Company MNN/A25,000N/A$5,738.00
8/17/2021Walleye Trading LLC26,60065,900+147.7%$15,125.00
8/17/2021Logan Capital Management Inc.N/A25,000N/A$5,738.00
8/17/2021Millennium Management LLC295,900558,600+88.8%$128,210.00
8/17/2021Man Group plcN/A100N/A$23.00
8/17/2021Pathstone Family Office LLCN/A4,564N/A$1,048.00
8/17/2021Parallax Volatility Advisers L.P.342,7000-100.0%$0.00
8/17/2021Balyasny Asset Management LLCN/A133,800N/A$30,710.00
8/17/2021Caas Capital Management LP52,00014,000-73.1%$3,213.00
8/17/2021Citadel Advisors LLC859,8001,094,500+27.3%$251,210.00
8/16/2021Squarepoint Ops LLC13,70048,200+251.8%$11,063.00
8/16/2021Bank of America Corp DE81,500203,300+149.4%$46,661.00
8/16/2021SG3 Management LLC18,50031,100+68.1%$7,138.00
8/16/2021Credit Suisse AG165,300250,500+51.5%$57,457.00
8/16/2021Maven Securities LTD4,9001,400-71.4%$321.00
8/16/2021Jefferies Group LLC26,500100,000+277.4%$230.00
8/16/2021Goldman Sachs Group Inc.172,40057,400-66.7%$13,174.00
8/16/2021Allianz Asset Management GmbH30,30034,500+13.9%$7,918.00
8/13/2021PEAK6 Investments LLC23,80012,900-45.8%$2,961.00
8/13/2021Lavaca Capital LLCN/A5,200N/A$1,194.00
8/13/2021SpiderRock Advisors LLC88,40078,300-11.4%$10,092.00
8/12/2021Simplex Trading LLC2,746194,100+6,968.5%$44,549.00
8/12/2021JPMorgan Chase & Co.77,40098,600+27.4%$22,630.00
8/12/2021Twin Tree Management LP652,600549,500-15.8%$126,121.00
8/12/2021Capital Fund Management S.A.43,00090,700+110.9%$20,817.00
8/11/2021HAP Trading LLC24,00016,600-30.8%$67.00
8/11/2021Susquehanna International Group LLP1,304,2001,621,200+24.3%$372,098.00
8/10/2021BNP Paribas Arbitrage SA274324+18.2%$7,436.00
8/10/2021Citigroup Inc.76,70098,800+28.8%$22,677.00
8/6/2021Wolverine Trading LLC108,800134,700+23.8%$30,896.00
8/6/2021IMC Chicago LLC103,300100,600-2.6%$23,090.00
8/5/2021US Bancorp DE88No Change$7.00
8/2/2021Mint Tower Capital Management B.V.5,8000-100.0%$0.00

Eli Lilly and (NYSE:LLY) Short Interest FAQ

speech bubbles
speech bubbles











What is Eli Lilly and's current short interest?

Short interest is the volume of Eli Lilly and shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 6,150,000 shares of LLY short. 0.77% of Eli Lilly and's shares are currently sold short. Learn More on Eli Lilly and's current short interest.

What is a good short interest ratio for Eli Lilly and?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Eli Lilly and currently has a short interest ratio of 2.0. Learn More on a good short interest ratio for Eli Lilly and

Which institutional investors are shorting Eli Lilly and?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eli Lilly and: Bank of America Corp DE, Pathstone Family Office LLC, Jefferies Group LLC, Wells Fargo & Company MN, Walleye Trading LLC, Logan Capital Management Inc., Millennium Management LLC, Man Group plc, Pathstone Family Office LLC, Parallax Volatility Advisers L.P., Balyasny Asset Management LLC, Caas Capital Management LP, Citadel Advisors LLC, Squarepoint Ops LLC, Bank of America Corp DE, SG3 Management LLC, Credit Suisse AG, Maven Securities LTD, Jefferies Group LLC, Goldman Sachs Group Inc., Allianz Asset Management GmbH, PEAK6 Investments LLC, Lavaca Capital LLC, SpiderRock Advisors LLC, Simplex Trading LLC, JPMorgan Chase & Co., Twin Tree Management LP, Capital Fund Management S.A., HAP Trading LLC, Susquehanna International Group LLP, BNP Paribas Arbitrage SA, Citigroup Inc., Wolverine Trading LLC, IMC Chicago LLC, US Bancorp DE, and Mint Tower Capital Management B.V.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Eli Lilly and?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.77% of Eli Lilly and's floating shares are currently sold short.

What is Eli Lilly and's float size?

Eli Lilly and currently has issued a total of 959,025,000 shares. Some of Eli Lilly and's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eli Lilly and currently has a public float of 795,050,000 shares.

How does Eli Lilly and's short interest compare to its competitors?

0.77% of Eli Lilly and's shares are currently sold short. Here is how the short interest of companies in the sub-industry of "pharmaceuticals" compare to Eli Lilly and: Johnson & Johnson (0.00%), Pfizer Inc. (0.00%), AbbVie Inc. (0.77%), Merck & Co., Inc. (0.00%), Bristol-Myers Squibb (0.92%), Zoetis Inc. (0.62%), Horizon Therapeutics Public Limited (1.85%), Royalty Pharma plc (1.80%), Jazz Pharmaceuticals plc (6.23%), and Perrigo Company plc (3.41%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short Eli Lilly and stock?

Short selling LLY is an investing strategy that aims to generate trading profit from Eli Lilly and as its price is falling. Eli Lilly and's stock is trading down $3.27 today. To short Eli Lilly and stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Eli Lilly and will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Eli Lilly and?

A short squeeze for Eli Lilly and occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LLY, which in turn drives the price of the stock up even further.

How often is Eli Lilly and's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LLY, twice per month. The most recent reporting period available is August, 31 2021.



This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.